Skip to content

OneTouch Verio Flex 024-267Recalls & reported problems

LifeScan Europe GmbH · OneTouch Verio Flex Blood Glucose Monitoring System · Class 2

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00353885012485), received between Feb 19, 2025 and Feb 19, 2025 — classified as 2 injuries.

The most frequently reported specific device problem is “Device Displays Incorrect Message” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 2 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Device Displays Incorrect Message2

Patient problems

  • Anxiety2
  • Dizziness2
  • Nausea2
  • Syncope/Fainting2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryFeb 19, 2025Device Displays Incorrect Message; Device Displays Incorrect Message

    ON (B)(6) 2025, A LAY USER/PATIENT CONTACTED LIFESCAN (LFS) USA, ALLEGING THAT THEIR ONETOUCH VERIO FLEX METER WAS GENERATING ERROR 4 RESULTS. THIS COMPLAINT WAS CLASSIFIED BASED ON INFORMATION OBTAINED BY THE CUSTOMER CARE AGENT (CCA) DURING THE INITIAL CALL SINCE THE PATIENT COULD NOT BE REACHED TO OBTAIN ADDITIONAL INFORMATION. THE PATIENT STATED THAT THE ALLEGED ISSUE BEGAN ON THE MORNING OF (B)(6) 2024, AND THAT THEY HAD BEEN GETTING ERROR 4 MESSAGES FOR 2 WEEKS. EVER SINCE THE FIRST TIME HE USED 4 CONSECUTIVE STRIPS WHICH GENERATED ERROR 4 RESULTS, THE PATIENT HAS BEEN GETTING THE ERROR 4 MESSAGE CONSISTENTLY. SINCE (B)(6) 2024, THE PATIENT HAD FEELINGS OF ANXIETY AND ON (B)(6) 2025, THE PATIENT FELT DIZZY, NAUSEOUS AND FELL UNCONSCIOUS. IN RESPONSE TO THE ALLEGED ISSUE, THE CUSTOMER DID NOT TAKE ANY ACTION OR RECEIVE TREATMENT. THE PATIENT MANAGES THEIR DIABETES WITH GLIPIZIDE 5MG, AT BREAKFAST AND AT NIGHT. THE CCA NOTED THAT THE TEST STRIPS HAD BEEN REMOVED FROM THEIR ORIGINAL VIAL AND WERE BEING STORED A PILL CONTAINER. REPLACEMENT PRODUCTS WERE SENT TO THE PATIENT. THIS COMPLAINT IS BEING REPORTED BECAUSE THE PATIENT CLAIMS THEY WERE UNABLE TO TEST THEIR BLOOD GLUCOSE DU

    Patient problems: Anxiety; Dizziness; Nausea; Syncope/Fainting

    MAUDE report 21409086 ↗
  • InjuryFeb 19, 2025Device Displays Incorrect Message; Device Displays Incorrect Message

    ON (B)(6) 2025, A LAY USER/PATIENT CONTACTED LIFESCAN (LFS) USA, ALLEGING THAT THEIR ONETOUCH VERIO FLEX METER WAS GENERATING ERROR 4 RESULTS. THIS COMPLAINT WAS CLASSIFIED BASED ON INFORMATION OBTAINED BY THE CUSTOMER CARE AGENT (CCA) DURING THE INITIAL CALL SINCE THE PATIENT COULD NOT BE REACHED TO OBTAIN ADDITIONAL INFORMATION. THE PATIENT STATED THAT THE ALLEGED ISSUE BEGAN ON THE MORNING OF (B)(6) 2024, AND THAT THEY HAD BEEN GETTING ERROR 4 MESSAGES FOR 2 WEEKS. EVER SINCE THE FIRST TIME HE USED 4 CONSECUTIVE STRIPS WHICH GENERATED ERROR 4 RESULTS, THE PATIENT HAS BEEN GETTING THE ERROR 4 MESSAGE CONSISTENTLY. SINCE (B)(6) 2024, THE PATIENT HAD FEELINGS OF ANXIETY AND ON (B)(6) 2025, THE PATIENT FELT DIZZY, NAUSEOUS AND FELL UNCONSCIOUS. IN RESPONSE TO THE ALLEGED ISSUE, THE CUSTOMER DID NOT TAKE ANY ACTION OR RECEIVE TREATMENT. THE PATIENT MANAGES THEIR DIABETES WITH GLIPIZIDE 5MG, AT BREAKFAST AND AT NIGHT. THE CCA NOTED THAT THE TEST STRIPS HAD BEEN REMOVED FROM THEIR ORIGINAL VIAL AND WERE BEING STORED A PILL CONTAINER. REPLACEMENT PRODUCTS WERE SENT TO THE PATIENT. THIS COMPLAINT IS BEING REPORTED BECAUSE THE PATIENT CLAIMS THEY WERE UNABLE TO TEST THEIR BLOOD GLUCOSE DU

    Patient problems: Anxiety; Dizziness; Nausea; Syncope/Fainting

    MAUDE report 21409073 ↗

Other Glucose Dehydrogenase, Glucose devices

All Glucose Dehydrogenase, Glucose devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.